Best Agrolife Ltd

Best Agrolife Ltd

₹ 16.0 -1.24%
08 Jun - close price
About

Best Agrolife (formerly known as Sahyog Multibase Limited) [1] is a leading agrochemicals manufacturer in India and is among the top 15 agrochemicals companies in the country. It is one of the fastest growing manufacturers of Technicals, Formulations, Intermediates and Public Health products. Best Agrochem Private Limited was amalgamated with the Co. in April 2018.

It offers more than 70 Formulations in the form of Insecticides, Herbicides, Fungicides and Plant Growth Regulators, which are developed from active ingredients manufactured in-house. As part of its P2P set-up, Best Agrolife caters to several blue-chip corporates and leading MNCs from India and abroad. [2]

Key Points

Business Overview
The company is the 13th Largest Indian Agrochemical Company, with a portfolio of 525+ formulations and 123+ technical manufacturing licenses. It offers a wide range of herbicides, insecticides, fungicides, and plant growth regulators including Ronfen, Citigen, Tricolor, Azaro, Cubax Power, etc. [1] [2] [3]

  • Market Cap 566 Cr.
  • Current Price 16.0
  • High / Low 35.8 / 12.3
  • Stock P/E 18.6
  • Book Value 13.2
  • Dividend Yield 1.25 %
  • ROCE 10.5 %
  • ROE 6.66 %
  • Face Value 1.00

Pros

  • Company's median sales growth is 27.8% of last 10 years

Cons

  • The company has delivered a poor sales growth of 0.04% over past five years.
  • Company has a low return on equity of 7.21% over last 3 years.
  • Working capital days have increased from 62.8 days to 94.9 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
260 613 734 348 104 361 434 193 156 313 365 129 100
295 576 690 349 121 321 371 190 159 283 304 128 123
Operating Profit -35 36 44 -1 -17 40 63 4 -4 30 62 0 -23
OPM % -14% 6% 6% -0% -16% 11% 15% 2% -2% 10% 17% 0% -23%
1 5 -2 2 2 2 2 1 1 5 -1 2 3
Interest 8 8 11 14 10 11 11 11 8 8 8 9 6
Depreciation 2 1 2 2 2 2 2 2 2 2 1 2 2
Profit before tax -43 32 30 -15 -28 30 52 -8 -13 26 52 -8 -28
Tax % -25% 26% 26% -24% -24% 25% 27% -25% -25% 25% 26% -25% -23%
-32 24 22 -12 -21 22 38 -6 -9 20 38 -6 -22
EPS in Rs -0.91 0.67 0.63 -0.33 -0.59 0.62 1.08 -0.17 -0.27 0.55 1.08 -0.16 -0.61
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 9 99 129 663 690 905 1,134 1,500 1,798 1,144 907
0 9 98 132 652 675 854 1,009 1,414 1,736 1,041 838
Operating Profit -0 -0 1 -3 11 15 51 125 86 62 103 69
OPM % -2% 1% -2% 2% 2% 6% 11% 6% 3% 9% 8%
0 0 0 4 2 4 7 5 10 6 6 10
Interest 0 0 1 1 5 6 5 11 24 43 41 30
Depreciation 0 0 0 0 1 2 3 4 5 7 7 6
Profit before tax 0 0 0 0 7 12 51 116 67 19 61 42
Tax % 20% 43% 567% 175% 36% 29% 27% 25% 30% 30% 27% 28%
0 0 -0 -0 5 8 37 87 47 13 44 30
EPS in Rs 0.01 0.01 -0.03 -0.00 0.39 0.69 1.12 2.45 1.33 0.38 1.25 0.86
Dividend Payout % 0% 76% -57% -399% 0% 3% 12% 5% 15% 53% 16% 0%
Compounded Sales Growth
10 Years: 59%
5 Years: 0%
3 Years: -15%
TTM: -21%
Compounded Profit Growth
10 Years: 94%
5 Years: -4%
3 Years: -14%
TTM: -32%
Stock Price CAGR
10 Years: 28%
5 Years: -4%
3 Years: -39%
1 Year: -28%
Return on Equity
10 Years: 12%
5 Years: 12%
3 Years: 7%
Last Year: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3 3 8 8 22 22 22 24 24 24 24 35
Reserves 0 0 41 43 156 62 108 289 336 342 420 434
0 0 0 8 39 35 32 137 286 348 252 205
0 1 38 22 265 217 209 260 283 443 279 228
Total Liabilities 3 4 87 81 482 336 371 709 928 1,157 975 902
0 0 0 0 110 15 19 21 33 32 34 33
CWIP 0 0 0 0 0 0 0 0 0 1 1 1
Investments 0 0 26 3 4 5 0 102 102 116 122 122
3 4 60 78 369 315 352 586 793 1,007 819 746
Total Assets 3 4 87 81 482 336 371 709 928 1,157 975 902

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -0 -13 -35 60 16 10 -0 -128 -35 131 123
0 0 -36 25 -5 -5 12 -97 55 -20 -14 -37
0 0 48 11 -45 -13 -12 90 118 12 -107 -85
Net Cash Flow 0 0 -0 0 11 -3 10 -8 45 -42 9 1
Free Cash Flow 0 -0 -13 -35 53 12 7 -7 -135 -41 127 120
CFO/OP -367% 129% -1,211% 1,209% 555% 124% 41% 22% -104% -35% 134% 199%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 88 72 86 112 92 53 75 73 66 103 110
Inventory Days 0 31 31 43 42 67 77 90 86 122 134
Days Payable 75 53 141 101 72 82 63 83 84 81
Cash Conversion Cycle 88 29 63 14 33 48 70 100 69 141 164
Working Capital Days 111 76 156 14 24 34 50 32 28 66 95
ROCE % 2% 2% 5% -2% 8% 11% 40% 41% 17% 9% 14% 11%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of Distributors
Count

Log in to view insights

Please log in to see hidden values.

Login
Total Headcount (Employees)
Count
Formulations Manufacturing Capacity
MTPA/KL
Formulations Registrations (India)
Count
Technicals Manufacturing Capacity
MTPA

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.10% 50.44% 50.44% 50.44% 50.44% 50.44%
10.84% 9.86% 8.86% 8.77% 8.73% 8.03% 5.11% 5.80% 5.75% 5.75% 5.63% 5.53%
2.55% 2.63% 2.53% 2.53% 2.53% 2.67% 2.74% 2.74% 2.74% 2.11% 2.11% 2.11%
36.50% 37.42% 38.50% 38.60% 38.62% 39.18% 42.06% 41.01% 41.05% 41.70% 41.82% 41.94%
No. of Shareholders 27,20031,94037,57139,86141,57040,57337,66637,49436,63037,18138,18068,254

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls